← SynDRA
TENELIGLIPTIN
SynDRA canonical compound SYN0033881 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | DPP4 |
|---|
| Mechanism of action | Dipeptidyl peptidase inhibitor |
|---|
| Indication | diabetes mellitus |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- Dipeptidyl peptidase inhibitor
- DPP4 inhibitor
- DPP4 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HRH1
- HDAC6
- HRH3
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- KDR
- MAOA
- MC3R
- MLNR
- ACHE
- NR3C1
- OPRD1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PPARG
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- NR1I2
- GHSR
- ADORA1
- FAP
- ADORA2A
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- CCKAR
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- teneligliptin hydrobromide
- teneligliptin hydrobromide hydrate
- tenelia
- Teneligliptine
- Teneligliptina
- MP-513
- UNII-28ZHI4CF9C
- Teneligliptin [INN]
- 28ZHI4CF9C
- Teneligliptin hydrobromide
- CHEMBL2147777
- Teneligliptin (INN)
- [(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone
- C22H30N6OS
- {(2s,4s)-4-[4-(3-Methyl-1-Phenyl-1h-Pyrazol-5-Yl)piperazin-1-Yl]pyrrolidin-2-Yl}(1,3-Thiazolidin-3-Yl)methanone
- Teneli
- SCHEMBL161778
- GTPL9906
- WGRQANOPCQRCME-PMACEKPBSA-N
- CHEBI:136042
- MolPort-039-139-824
- MP513
- ZINC36520254
- BDBM50391565
- teneligliptina
- teneligliptine
- teneligliptinum
- RefChem:187831
- Teliglietin
- MFCD13195565
- CS-0882
- Teneligliptin (Standard)
- TENELIGLIPTIN [MI]
- TENELIGLIPTIN [WHO-DD]
- orb1692821
- GLXC-15822
- HY-14806R
- MSK167109
Look up TENELIGLIPTIN in the interactive SynDRA portal →